Showing results (1431-1440 of 1,840) with videos related to

Sort By:
Pageof 184
Journal of Medicinal Chemistry|February 28, 2024
Structure-Based Design of Novel G-Protein-Coupled Receptor TAAR1 Agonists as Potential Antipsychotic Drug CandidatesZhenzhen Zhou, Weifeng Zhang, Fabao Zhao, et al.
Marine Drugs|March 27, 2024
Study on the Anti-Mycobacterium marinum Activity of a Series of Marine-Derived 14-Membered Resorcylic Acid Lactone DerivativesQian-Qian Jing, Jun-Na Yin, Ya-Jie Cheng, et al.
Nucleic Acids Research|February 23, 2021
Mechanisms of spacer acquisition by sequential assembly of the adaptation module in SynechocystisChengyong Wu, Dongmei Tang, Jie Cheng, et al.
Neurobiology of Disease|December 18, 2019
Curcumin attenuates cognitive impairment by enhancing autophagy in chemotherapyLi-Tao Yi, Shu-Qi Dong, Shuang-Shuang Wang, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|July 2, 2013
Identification of 2-piperidone as a biomarker of CYP2E1 activity through metabolomic phenotypingJie Cheng, Chi Chen, Krausz W Kristopher, et al.
Biomedical Chromatography : BMC|February 3, 2012
Comprehensive chemical profiling of guizhi fuling capsule by the combined use of gas chromatography-mass spectrometry with a deconvolution software and rapid-resolution liquid chromatography quadrupole time-of-flight tandem mass spectrometryYa-Qiong Wang, Lian-Wen Qi, Jiye Aa, et al.
Molecular Plant-Microbe Interactions : MPMI|February 3, 2021
Residues R192 and K225 in RNA-Binding Pocket of Tobacco Vein Banding Mosaic Virus CP Control Virus Cell-to-Cell Movement and ReplicationZhi-Yong Yan, Xiao-Jie Xu, Le Fang, et al.
Disease Markers|March 14, 2017
The Impact of tagSNPs in CXCL16 Gene on the Risk of Myocardial Infarction in a Chinese Han PopulationShun Xu, Jie Cheng, Meng-Yun Cai, et al.
Gut Microbes|February 25, 2025
Indole derivatives ameliorated the methamphetamine-induced depression and anxiety via aryl hydrocarbon receptor along "microbiota-brain" axisXi Wang, Miaoyang Hu, Weilan Wu, et al.
Clinical Pharmacology in Drug Development|December 6, 2023
A Randomized, Single-Dose, Parallel-Controlled Phase 1 Clinical Comparison of an Omalizumab Biosimilar Candidate with Reference Omalizumab in Healthy Chinese Male VolunteersJie Cheng, Chenguang Wang, Jin Xu, et al.
Pageof 184